If you’ve scrolled past a K-beauty serum or a “baby skin injection” clinic ad lately, you’ve probably already encountered PDRN without knowing its name.
Polydeoxyribonucleotide — usually shortened to PDRN — has moved from dermatology clinics into mainstream skincare shelves, and is now beginning to appear in oral supplement form as well. For brand owners watching the beauty-and-wellness convergence, it’s a genuinely rare case of an ingredient with real clinical history behind the hype.
What PDRN Actually Is
PDRN is a compound made of purified DNA fragments, most commonly extracted from salmon or trout milt (reproductive tissue) — chosen because its DNA structure is highly compatible with human tissue. It isn’t a new discovery dressed up in trendy packaging: PDRN was developed in Italy in the 1980s for regenerative medicine, where it was studied for helping chronic wounds and diabetic ulcers heal.
At the cellular level, PDRN works by binding to A2A adenosine receptors, which helps stimulate cell growth, encourage tissue repair, and reduce inflammation. That mechanism is what eventually carried it from hospital wound care into aesthetic medicine, and from there into consumer skincare.
Why It’s Trending Now
A few things have converged to push PDRN into the mainstream:
- The shift from “aggressive” to “restorative” skincare. Consumers are moving away from harsh exfoliation and toward routines focused on barrier repair and skin resilience — exactly the positioning PDRN’s wound-healing background supports.
- K-beauty’s influence on global trends. Korean formulators have led the charge in translating PDRN from clinic treatments into topical serums and ampoules, and as with previous K-beauty breakouts (snail mucin, centella asiatica, niacinamide), global markets have followed.
- A built-in credibility story. In a market saturated with ingredients whose only “research” is a viral TikTok, brands can point to decades of published clinical literature behind PDRN — a meaningfully different pitch than most trending actives can offer.
- Crossover from clinic to home-use. What used to require an injectable treatment at a clinic is now available in serum, ampoule, and increasingly oral supplement form, widening the addressable market well beyond aesthetic clinic patients.
Topical PDRN: What Brand Owners Should Know
In skincare formulations, PDRN is typically positioned around:
- Barrier support and skin recovery — rebuilding and strengthening the skin’s protective outer layer
- Post-procedure and sensitive skin care — calming and supporting skin after treatments like microneedling or laser
- General anti-aging and elasticity support — as a newer alternative or complement to peptides and retinol
One important formulation caveat: topical absorption of PDRN is far more limited than injectable delivery. Ingredient stability and delivery system matter significantly for whether a topical product performs — this is an area where formulation expertise (rather than simply sourcing the raw ingredient) makes a real difference in product efficacy.
Plant-derived and fermentation-derived PDRN alternatives are also emerging, which may appeal to brands wanting to avoid marine-sourced ingredients for cost, supply chain, or halal/vegan positioning reasons — worth discussing with your formulation partner depending on your target market.
The Emerging Oral Supplement Angle
Because injectable PDRN faces regulatory restrictions in many markets and topical absorption has real limits, formulation science is increasingly exploring oral PDRN supplements as a non-invasive, systemic alternative.
The positioning logic is straightforward: rather than delivering PDRN to one treated area, an oral format offers full-body exposure, tapping into the same regenerative and anti-inflammatory mechanism for broader wellness and healthy-aging claims rather than a single cosmetic outcome.
This is still an early-stage category — nowhere near as established as collagen or NMN supplements — which makes it an interesting opportunity for brands wanting to move early on an ingredient story, provided the claims stay appropriately conservative given the limited oral-specific research relative to its topical and injectable history.
Regulatory Considerations in Malaysia
Any brand considering PDRN — topical or oral — needs to plan formulation and claims carefully:
- Sourcing documentation matters. Marine-derived PDRN requires clear sourcing and purification documentation, particularly important for halal certification given its animal origin — a key consideration if halal positioning matters for your target market.
- Avoid injectable-adjacent claims. Topical and oral products must be clearly differentiated from injectable/clinical PDRN treatments in marketing language — implying equivalent results to a clinic procedure risks regulatory issues.
- Oral claims need conservative framing. Given how new oral PDRN supplementation is, claims should stay grounded in general wellness and cellular health language rather than specific regenerative promises, and should be supported by appropriate documentation in the NPRA submission dossier.
Where This Leaves Brand Owners
PDRN offers something increasingly rare in the ingredient trend cycle: a genuine science-backed story that consumers are actively searching for, with room to differentiate through format (serum vs. ampoule vs. oral), source (marine vs. plant-derived), and positioning (targeted skincare vs. systemic wellness).
Brands that move early — with formulation partners who can navigate both the technical delivery challenges and the regulatory nuances — have a real opportunity to establish themselves before the category becomes crowded.
Exploring a PDRN-based skincare or supplement product? Novaxis Health can help you evaluate sourcing options, formulation approach, and MOH registration pathway. Contact us to discuss your concept.